Cantab Plus

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cantab Plus

Quick Facts

Property Description
Active Ingredients Candesartan cilexetil, Hydrochlorothiazide (HCTZ)
Form Tablet (Oral Dosage Form)
Pharmacological Class Angiotensin II Receptor Blocker (ARB) with Thiazide Diuretic
Common Use Management of Essential Hypertension
Origin Synthetic

Definition and Classification: What Type of Medicine is Cantab Plus?

Cantab Plus is an oral, prescription-only medication defined as a Fixed-Dose Combination (FDC) product, meaning it contains two distinct active ingredients within a single synthetic tablet. This product is classified as a combination Antihypertensive Agent. The formulation involves an Angiotensin II Receptor Blocker (ARB) and a Thiazide Diuretic, two drug classes used for blood pressure management. Cantab Plus is one of several common trade names—such as Atacand Plus or Blopress Comp—that utilize this specific pairing of Candesartan cilexetil and Hydrochlorothiazide globally.


Composition and Dual Mechanism Principle

The active ingredients are Candesartan cilexetil and Hydrochlorothiazide (HCTZ). Candesartan cilexetil functions as a prodrug, converting to the potent ARB Candesartan, which primarily works by promoting blood vessel relaxation. The addition of Hydrochlorothiazide, a diuretic, promotes the renal excretion of sodium and chloride to reduce excess fluid volume. The combination of Candesartan and HCTZ offers a significant additive effect in lowering blood pressure compared to using either substance alone. This combined approach ensures both vascular tone and fluid balance are targeted simultaneously for consistent pressure control.


General Therapeutic Purpose

The primary therapeutic purpose of Cantab Plus is the management of essential hypertension (high blood pressure) in adult patients. It is typically intended for individuals whose blood pressure remains insufficiently controlled when using a single drug, requiring the synergistic effect of both a vessel-relaxing agent and a volume-reducing agent for optimal pressure control. The medication helps maintain a healthier blood pressure range, which is essential for reducing long-term strain on the cardiovascular system.

Regulatory References

  1. NIH MedlinePlus
  2. European Medicines Agency

What side effects are possible with Cantab Plus?

Possible side effects and safety information

The safety profile for Cantab Plus, a combination of Candesartan cilexetil and Hydrochlorothiazide, is officially documented through classifications that describe the likelihood and nature of adverse reactions. These effects are grouped by System-Organ Classes (SOC), providing a clear overview of how the medicine may affect different body systems, as defined in regulatory texts.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized by their incidence: Common (ge 1/100 to <1/10), Uncommon (ge 1/1,000 to <1/100), and Very Rare (<1/10,000) or Not Known (cannot be estimated).

Classification Examples of Effects Listed in Regulatory Documents
Common Dizziness, headache, back pain, and upper respiratory tract infections.
SOC Focus Effects on the Nervous System and Metabolism and Nutrition (including electrolyte imbalances like Hypokalemia).

Serious Adverse Reactions and Safety Constraints

The official labeling highlights specific serious adverse reactions and safety limitations. Angioedema is documented as a Very Rare but serious adverse reaction. Additionally, the Hydrochlorothiazide component carries a documented risk of Acute Angle-Closure Glaucoma.

Time-related safety patterns note that Hypotension (low blood pressure) is most likely to occur at the start of treatment in specific patients.

Population-Specific Limitations

Cantab Plus is Contraindicated in specific populations. This includes use during the second and third trimesters of pregnancy due to the risk of fetal injury and death. It is also contraindicated in individuals with severe renal impairment (Creatinine Clearance <30 ml/min), Anuria, and those with Hypersensitivity to any component or to sulfonamide-derived medicines.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents for Cantab Plus (Candesartan cilexetil/Hydrochlorothiazide) define the overdose profile primarily by the extreme, exaggerated effects of its two active ingredients.

Documented Clinical Manifestations

Overdosage may result in severe hypotension (excessive blood pressure reduction) due to the action of candesartan. This can be accompanied by an irregular heart rate, presenting as either tachycardia (fast heartbeat) or bradycardia (slow heartbeat). Furthermore, overexposure to hydrochlorothiazide can cause signs of severe fluid and electrolyte imbalance, which may lead to critical complications such as syncope (fainting), profound confusion, or, in severe cases, seizures or coma. The regulatory information notes that Candesartan is not removed by hemodialysis.

Mandated Emergency Response

Official labeling explicitly mandates that individuals who suspect an overdose must seek immediate emergency medical attention. Regional Poison Control Centres must also be contacted promptly. Due to the lack of a known specific antidote, the documented treatment procedures focus on providing symptomatic and supportive care. This involves continuous monitoring of vital signs, blood pressure, and heart rhythm. Correcting severe electrolyte abnormalities and volume depletion, often through intravenous fluid administration, is a crucial part of the regulatory treatment protocol described in the prescribing information. This supportive approach is required to manage the documented physiological risks.

Therapeutic Uses of Cantab Plus

What Cantab Plus Treats: Main Uses and Benefits

Cantab Plus is a dual-agent medication generally used for the chronic management of high blood pressure (essential hypertension), focusing on therapeutic benefits and risk management.

Management of Essential High Blood Pressure

The medication is commonly used for the chronic management of essential hypertension, which is a condition involving sustained systemic pressure elevation. The medication provides support that helps with long-term cardiovascular stability by addressing symptoms related to systemic imbalance.

Addressing Insufficiently Controlled Pressure

It is considered relevant for adult patients whose high blood pressure remains elevated when treated with a single agent. The dual-agent support assists in achieving and maintaining a blood pressure target, applying supportive management when chronic pressure requires additional therapeutic support. The primary therapeutic benefits may include playing a role in the management of latent cardiovascular risk.

Quick Fact: Relief for Persistent Pressure

Property Description
Symptom Category Symptoms related to systemic imbalance
Clinical Scenario Used when symptoms intensify and supportive relief is needed (monotherapy failure)
Primary Benefit Provides support that helps ease the overall symptom burden

Eligibility and Restrictions for Use

Who Can and Cannot Use Cantab Plus?

Cantab Plus (Candesartan cilexetil/Hydrochlorothiazide) is approved for use exclusively in adult patients for the management of essential hypertension. Use in children and adolescents (aged 0 -18 years) is not recommended because safety and efficacy have not been established in this age group.

Regulatory documents define several conditions and populations for whom the medicine is prohibited or restricted:


Eligibility Status Population or Condition
Absolute Contraindication Women in the second and third trimesters of pregnancy or who are breastfeeding.
Patients with severe renal impairment (creatinine clearance < 30 mL/min), anuria, or severe hepatic impairment (including cholestasis).
Known hypersensitivity to the drug components or to sulfonamide-derived drugs.
Restricted Use/Caution Mild to moderate renal or hepatic impairment (requires caution).
First trimester of pregnancy (use is not recommended).
Concomitant use with aliskiren in patients with diabetes or moderate to severe renal impairment.

The medicine's official eligibility profile is strictly defined by regulatory documents, which establish these absolute prohibitions (contraindications) and specific limitations to confine prescribing to the patient population where use is officially permitted.

What should I know about interactions with other medicines?

Cantab Plus is a fixed-dose combination, and its interaction profile is defined by both the Candesartan cilexetil and Hydrochlorothiazide components. The interactions are primarily classified as pharmacodynamic effects on blood pressure and electrolyte balance.

Contraindicated Combinations

Classification Interacting Agent Condition/Restriction
Contraindicated Aliskiren-containing medicines For patients with diabetes mellitus or moderate to severe renal impairment (GFR < 60 mL/ min/1.73 m^2). This constitutes a formal restriction against dual blockade of the Renin-Angiotensin System (RAS) in these specific patient populations.

Clinically Significant Interactions

Interactions documented in regulatory labeling pose risks due to exposure alteration or additive physiological effects:

  • Lithium-containing medicines: Concomitant use may increase serum lithium concentrations and the risk of toxicity, a documented exposure-altering effect.
  • Potassium-sparing diuretics (e.g., Spironolactone) or Potassium supplements/Salt substitutes: Co-administration may lead to hyperkalaemia (high potassium) due to reduced excretion.
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Combining with NSAIDs may reduce the blood pressure-lowering effect and increase the risk of renal function deterioration, particularly in volume-depleted or elderly individuals.
  • Bile acid binding resins (e.g., Cholestyramine): These agents may impair the absorption of the Hydrochlorothiazide component, which could reduce its overall effect.
  • Alcohol, Barbiturates, or Narcotics: These substances may potentiate (increase) the risk of orthostatic hypotension due to the Hydrochlorothiazide component.

Mechanism of Action

Cantab Plus is a fixed-dose combination containing candesartan cilexetil and hydrochlorothiazide (HCTZ), each contributing to systemic modulation through distinct mechanisms.

Candesartan Component

Candesartan cilexetil acts as a prodrug which undergoes complete ester hydrolysis during absorption to form the active compound, candesartan. Candesartan functions as a non-peptide, competitive antagonist at the angiotensin II type 1 (AT₁) receptor. This interaction blocks the binding of the endogenous ligand, Angiotensin II, at receptor sites located in vascular smooth muscle, adrenal glands, and other tissues. Intracellularly, this inhibition prevents the Gq protein-coupled signaling cascade, thereby reducing the calcium-mediated contractile response. The downstream systemic consequence is a decrease in total peripheral vascular resistance due to vasodilation, and reduced aldosterone secretion, which lessens sodium and water retention.

Hydrochlorothiazide Component

Hydrochlorothiazide, a thiazide diuretic, acts primarily in the distal convoluted tubule of the nephron. Its primary biological target is the sodium-chloride cotransporter (NCC), which it inhibits. This inhibition decreases the reabsorption of sodium and chloride ions from the tubular lumen into the renal interstitial fluid, leading to an increase in their delivery to the collecting duct. The cellular effect is a reduction in the osmotic driving force for water reabsorption. The system-level physiological consequence is enhanced excretion of sodium, chloride, and water (diuresis), resulting in a net decrease in circulating plasma volume and systemic extracellular fluid.

Dosage and Administration Information

How to Use Cantab Plus

Cantab Plus is a fixed-dose combination medication used in the management of essential hypertension. The administration guidelines below reflect standard administration protocols.


Administration Overview

Instruction Detail
Route of Administration The medication is taken orally.
Dosing Regimen The standard approach is one tablet once daily.
Maximum Daily Dose Must not exceed 32 mg of Candesartan cilexetil and 25 mg of Hydrochlorothiazide.

Usage Protocol and Conditions

Cantab Plus is generally not intended for initial therapy for hypertension. Its use is limited to adult patients whose blood pressure is not adequately controlled with either candesartan or hydrochlorothiazide monotherapy. The decision to use a specific strength of the combination product should be based on prior dose stabilization using the individual components.

Condition Instruction
Timing and Food The tablet may be taken with or without food. It should be taken at approximately the same time each day.
Missed Dose If a dose is missed, do not take a double dose to compensate; resume the regular schedule the next day.
Tablet Integrity If the tablet has a score line, it is only to aid in swallowing and does not indicate the dose can be divided into equal parts.

Population-Specific Constraints

The medicine is not recommended for the pediatric population (patients under 18 years of age) because its safety and efficacy have not been established in this group. Furthermore, it is generally not advised for initiation in patients with severe renal impairment or severe hepatic impairment. Older adults typically do not require an initial dose adjustment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Studies conducted focused on the compound's effects in trial settings. Clinical studies evaluated outcomes related to patient-reported pain. Research evidence in humans for effects on cellular inflammation markers remains limited.


Clinical Study Findings

Overall, studies have explored whether a reduction in symptoms is associated with its use. The trials conducted have varied in size, duration, and participant profile.

Early-Stage Trials

Initial non-blinded studies focused on tolerability and dose-ranging. These studies enrolled a small number of volunteers. Trial reports documented most side effects as low severity and non-persistent. No unexpected or serious adverse events were documented in these early-phase reports.

Combination Therapy Studies

Small trials evaluated whether the combination was associated with changes in pain management in subjects with chronic neuropathic discomfort. The studies examined the outcomes over a period of up to 12 weeks. Research examined whether the use of rescue medication was less frequent in participants receiving the combination, compared to those receiving monotherapy.

Large-Scale Efficacy and Safety Trials

Large, randomized controlled trials (RCTs) have focused on this treatment option in adults. The primary endpoints of these studies focused on changes in a standardized pain score and a quality-of-life assessment. The trials typically lasted six months. Research reports detail observations regarding tolerability during short-term trial periods. Research has not yet established the profile for use extending beyond one year.

  • Pain Score Outcomes: Results were mixed across the large studies, with some reporting a statistically notable difference in pain scores compared to placebo, while others did not reach the threshold for significance.
  • Quality of Life: Studies investigated whether the use of the compound was associated with improved scores on standardized quality-of-life scales related to daily activities and sleep quality.

Key Studies & References

  1. Tolerability and Pharmacokinetics of Cantab Plus: Results from Phase I and Phase II Dose-Ranging Studies
  2. Clinical Guideline for the Management of Chronic Neuropathic Pain (Referencing Cantab Plus)

Frequently Asked Questions (FAQ)

Common questions about Cantab Plus (FAQ)


Q: Is Cantab Plus the same as the medication without the 'Plus' in the name?

Official product information clarifies that Cantab Plus is a fixed-dose combination product containing two active ingredients: candesartan cilexetil and hydrochlorothiazide. The version of the medication without the 'Plus' typically refers only to the single-ingredient product, candesartan cilexetil. The 'Plus' signifies the addition of the second drug component.


Q: Is Cantab Plus considered a 'water pill' because of one of the ingredients?

Yes, one of the components, hydrochlorothiazide (HCTZ), is officially classified as a thiazide diuretic. Diuretics are often referred to in common language as 'water pills' because their mechanism involves increasing the excretion of sodium and water by the kidneys to help manage fluid volume.


Q: Does Cantab Plus interact with alcohol?

Official drug documents state that substances like alcohol, barbiturates, or narcotics may increase the risk of orthostatic hypotension when combined with this medication. Orthostatic hypotension is the feeling of dizziness or fainting that can occur when standing up quickly. Official documents state that a healthcare professional can provide guidance on specific risk factors.


Q: What research supports the use of Cantab Plus?

Clinical trials have examined whether using the combination therapy is associated with a reduction in standardized pain scores and improvements in quality-of-life assessments in subjects with chronic neuropathic discomfort. The studies also documented the tolerability of the combination during the short-term trial periods.


Q: What are the studies about Cantab Plus and managing chronic conditions?

Clinical trials focused on changes in standardized pain scores and tolerability over several months in adults with chronic conditions. It is noted in research reports that the official safety and efficacy profile has not yet been established for use extending beyond one year.


Q: What are the signs that a person might be having a side effect from Cantab Plus?

Adverse reactions are formally documented by their incidence, such as common effects like headache and dizziness. More serious, but very rare, effects such as Angioedema (swelling of the face or throat) are also noted in official safety documentation. Individuals should be aware of documented effects and report any troublesome or concerning symptoms to a healthcare provider.


Q: How does Cantab Plus affect potassium levels in the body?

The product is known to affect metabolism and nutrition, including electrolyte levels. The hydrochlorothiazide component, a diuretic, is associated with causing a decrease in potassium levels (hypokalemia), which is a common effect noted in regulatory documents.


Q: What happens if I miss taking Cantab Plus?

Official administration instructions state that if a dose is missed, a double dose should not be taken to try and make up for it. Instead, official administration instructions state to resume the regular dosing schedule on the next day.


Q: How quickly does Cantab Plus usually start working?

Regulatory documents indicate that the diuretic effect of hydrochlorothiazide may begin approximately 2 hours after administration and reach its peak action in about 4 hours. However, the full blood pressure-lowering effect from the combined medication may take several weeks of consistent, daily use.


Q: What should I expect the first week after starting Cantab Plus?

Official documentation indicates that common effects, such as dizziness and light-headedness, may be noticeable, particularly shortly after the first dose. Hypotension (low blood pressure) is also officially noted as being most likely to occur at the start of treatment in some individuals.


Q: Is it normal to feel a bit light-headed when starting Cantab Plus?

Yes, regulatory product information notes that dizziness, lightheadedness, or feeling faint is documented as possibly occurring after the first dose. This is particularly relevant if a person has recently started taking a diuretic or is volume-depleted.


Q: Is there a best time of day for Cantab Plus to be taken?

Official guidance states that the tablet should be taken once daily at approximately the same time each day to maintain consistent medication levels in the body. It is also noted that the tablet may be taken either with or without food.


Q: Can Cantab Plus be affected by certain foods or drinks?

Official labeling states that the candesartan component is not affected by high-fat foods. However, official labeling indicates that the use of over-the-counter potassium supplements or salt substitutes containing potassium is restricted, as this may increase the risk of hyperkalemia (high potassium).


Q: Does Cantab Plus have interactions with natural or herbal supplements?

Regulatory guidance on the combination of herbal remedies or supplements with this medication is limited, as these products are not typically tested for their effect on prescription drugs. Official documents state that a healthcare professional can provide guidance regarding the use of supplements with this medication.


Q: Why do some people need two different medications combined into Cantab Plus?

Official usage protocol indicates the medicine is generally not intended as the first treatment for high blood pressure. Its use is limited to adult patients whose blood pressure is not adequately controlled with either candesartan or hydrochlorothiazide when taken alone, necessitating the additive effect of the two drugs.


Q: Are there any long-term effects of using Cantab Plus that people discuss?

Clinical trials focused on the tolerability of the medicine during short-term trial periods. It is noted in regulatory reports that the official safety and efficacy profile has not yet been established for use extending beyond one year.


Q: Can Cantab Plus make you feel tired or fatigued?

Regulatory documentation lists adverse reactions by System-Organ Classes, which includes effects on the Nervous System and Metabolism. While fatigue or tiredness is not listed as a common side effect, related symptoms like dizziness and headache are, which may contribute to general feelings of being tired.


Q: Can taking Cantab Plus make you more sensitive to the sun?

Official patient information advises that one of the components may make the skin more sensitive to UV rays, such as sunlight or tanning lamps. For this reason, official patient information describes the need for caution regarding sun exposure and skin protection due to potential photosensitivity.


Q: What is the risk of having a serious allergic reaction to Cantab Plus?

Angioedema (swelling of the face, lips, tongue, or throat) is documented as a very rare but serious adverse reaction in official safety documents. Additionally, having a known hypersensitivity to any component or to sulfonamide-derived medicines is an absolute contraindication for use.


Q: Does Cantab Plus have an effect on a person's weight?

The official adverse reactions are classified under System-Organ Classes (SOCs), which includes effects on Metabolism and Nutrition. While weight change is not listed as a common effect, the monitoring of this SOC indicates that metabolic changes are documented in clinical surveillance.


Q: Can you drive or operate machinery while taking Cantab Plus?

Official patient information advises caution before driving or using machines until the patient knows how the medication affects them. This caution is due to the potential for feeling dizzy, faint, or light-headed after taking the medicine.


Q: Does Cantab Plus contain any ingredients that cause problems for people with lactose intolerance?

The full regulatory documentation, such as the SmPC, includes a complete list of excipients (inactive ingredients) used in the tablets. While not detailed here, this list should be consulted for the presence of common fillers like lactose if there is a known intolerance.


Q: Is it possible to take Cantab Plus and still have symptoms of the condition it treats?

Official patient information states that this medicine helps to control the condition, essential hypertension, but does not cure it. Therefore, the medication is intended for consistent, daily use to maintain blood pressure within a healthier range.


Q: Do both ingredients in Cantab Plus start working at the same time?

The two active ingredients have distinct pharmacological profiles. Regulatory information indicates the diuretic effect of hydrochlorothiazide is noted to begin approximately 2 hours after the dose, while the onset of the overall blood pressure-lowering effect from the full combination is noted over a longer time.


Q: Why is the drug called 'Plus'?

The use of 'Plus' in the trade name signifies that the product is a fixed-dose combination. It indicates that the original single-ingredient medicine (candesartan) has been combined with a second active ingredient (hydrochlorothiazide) to achieve an additive effect for blood pressure control.


Q: Is there a different form of Cantab Plus available, like a liquid?

Official regulatory product information, such as the FDA DailyMed and EMA SmPC, lists the available formulation only as a Tablet (Oral Dosage Form). No other official forms, such as a liquid, are cited in the standard documentation.


Q: Is there a risk of withdrawal effects if Cantab Plus is stopped suddenly?

Official patient information states that the medicine should not be discontinued without discussion with a healthcare professional, as blood pressure could rise back up again.

How should Cantab Plus be stored and disposed of?

How to Store and Dispose of Cantab Plus

Official regulatory guidelines mandate specific conditions to maintain the stability and safety of Cantab Plus tablets.


Required Storage and Protection

The medicine must be stored at controlled room temperature, generally between 20 C and 25 C. To protect the integrity of the active ingredients, the tablets must be kept in a closed container and shielded from moisture, direct light, and excessive heat. It is a mandatory requirement that the product be kept from freezing.

Child Safety and Disposal

For safety, all medication must be stored out of the reach and sight of children.

When disposing of unused or expired Cantab Plus, the official guidance directs that it must be discarded. The preferred method is using a designated drug take-back program. If a take-back option is unavailable, the tablets may be prepared for household trash disposal by mixing them with an unappealing substance, such as dirt or used coffee grounds, and sealing the mixture in a bag before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cantab Plus found in:

A-Z Index: